Skip to content
MedsAcross

Medicine

Acthar 40 units/0.5 mL injection

Corticotropin · Subcutaneous · Keenova ARD
Available on requestPrescription onlyUS FDA Cold chain

Acthar 40 units/0.5 mL injection is a prescription medicine containing Corticotropin for subcutaneous use, marketed by Keenova ARD, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store Acthar Gel vial and Acthar Gel single-dose pre-filled SelfJect injector…

Key facts

Active ingredient (INN)
Corticotropin
Brand
Acthar
Strength
40 units/0.5 mL
Dosage form
Injection
Route
Subcutaneous
Packs
4 trays
Marketing authorisation holder
Keenova ARD
Manufacturer
Keenova ARD
Origin register
US FDA, United States
Storage
Store Acthar Gel vial and Acthar Gel single-dose pre-filled SelfJect injector under refrigeration between 2°C to 8°C (36°F to 46°F) in the carton to protect from light. After removing the single-dose pre-filled SelfJect injector from the refrigerator, it can be stored at room temperature between 20°C to 25°C (68°F to 77°F) for up to 24 hours.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
H01AA01 Corticotropin
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 February 2024
Identifiers
RxCUI 309541, 1040025, 2685293 +3DailyMed set ID 7b48ddec-e815-45f4-9ca0-5c0daaf56f30NDC 63004-8711, 63004-8712Application NDA008372

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
4 tray in 1 carton / 1 syringe in 1 tray / 1 mL in 1 syringe63004-8711-4Keenova ARD29 February 2024
4 tray in 1 carton / 1 syringe in 1 tray / .5 mL in 1 syringe63004-8712-4Keenova ARD29 February 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 3 July 1950Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Corticotropin

Clinical summary

Corticotropin is an adrenocorticotropic hormone indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age, among other approved uses. It is available as injection for subcutaneous and intramuscular use. MedsAcross supplies Corticotropin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Corticotropin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Acthar 40 units/0.5 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.